I'm biased but diagnostic tests like the NETest could provide a lot of useful biologic information that can guide and support treatment decisions! @WrenLabs
🚨🆕Just out on @TheLancetOncol the TERAVOLT study, evaluating the impact of #COVID19 in pts w/ thoracic cancers #LCSM
👉🏻Our data suggest high mortality (33%) & low admission to ICU (10%) in pts w/ thoracic #cancer
Thanks @marinagarassino & @peters_solange
https://t.co/dC5IxJ8edH
“It might seem like an extra effort to get your child to wear a mask, but it’s worth it – and it sets a great example,” says our Nicole Rosburg.
Here are her tips for getting kids to wear a mask during the #COVID19 pandemic: https://t.co/5CRty1mHJd @KidsAndCancer #EndCancer
Blood genomic analysis and Wolfram type mathematical modelling/analysis are the future of the accurate prediction of the efficacy of disease management. Indubitably we need to move away from opinion, "consensus" and empiricism to facts not fallacies @stephen_wolfram
NANETS #COVID Guidelines #3. SSAs: Should octreotide or lanreotide be delayed or stopped in #NET?
“The balance of potential harms that may result from delaying or interrupting SSA treatment ... in NET patients is very uncertain”. #LetsTalkAboutNETs https://t.co/8ZzPTIT79h
The report shows a number that is a patient’s score. This ranges from 0-100. Scores from 0-20 fall into the normal category. 21-40 are in the stable disease category. 41-100 are in the progressive disease category. #Netcancers#NETs#NeuroendocrineCancer#LetsTalkAboutNETs
NETest provides an assessment of treatment responses in #NeuroendocrineCancer tumor patients with standard clinical assessment. Interpretation of the test will facilitate identification of active disease and enable a determination of the efficacy of the current treatment #NETest
Wren has developed the first multianalyte LDT that can function as a companion diagnostic for radiation-based therapies. This molecular-based blood test predicts the efficacy of treatment responses to PRRT. #Netcancers#NETs#NeuroendocrineCancer#LetsTalkAboutNETs#liquidbiopsy
Wren Laboratories is based in the US and UK. Our mission is to help physicians across the World to solve critical clinical questions using liquid biopsies combined with intricate genetic tools and complex biomathematics. #Netcancers#NETs#NeuroendocrineCancer#LetsTalkAboutNETs
@netcancerday Worldwide NET Cancer Awareness Day is just around the corner and we have prepared a series of posts about how Wren Laboratories provides clinicians and patients with the information to better manage treatment #Netcancers#NeuroendocrineCancer#LetsTalkAboutNETs
Multiple myeloma represents 1.8% of all cancer cases in the US. Learn about MMRFpatient resources during #BloodCancerAwarenessMonth: https://t.co/PSgkzx4pNL
Diagnosed with Neuroendocrine Cancer? - 10 questions to ask your doctor (and where to find a NET Specialist Worldwide) - Ronny Allan - Living with Neuroendocrine Neoplasms https://t.co/dlKdVz2xwo via @rightrelevance thanks @justagoodlife